| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 68.694 | 46.914 | 46.913 | 41.894 | 40.030 | 36.768 | 26.844 | 0 | 0 | 0 |
| Total Income - EUR | 69.703 | 47.032 | 46.912 | 41.933 | 40.030 | 36.768 | 26.844 | 0 | 0 | 0 |
| Total Expenses - EUR | 73.181 | 47.819 | 38.570 | 37.051 | 28.932 | 26.464 | 21.262 | 549 | 0 | 0 |
| Gross Profit/Loss - EUR | -3.478 | -787 | 8.342 | 4.882 | 11.097 | 10.303 | 5.581 | -549 | 0 | 0 |
| Net Profit/Loss - EUR | -3.478 | -1.337 | 7.873 | 4.463 | 9.897 | 9.200 | 4.873 | -549 | 0 | 0 |
| Employees | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Biogrand International Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 41.164 | 56.170 | 70.703 | 80.921 | 92.772 | 104.618 | 100.971 | 100.756 | 100.451 | 99.889 |
| Inventories | 30.883 | 50.618 | 66.672 | 78.188 | 90.745 | 101.748 | 97.854 | 98.157 | 97.860 | 97.313 |
| Receivables | 9.930 | 5.535 | 3.407 | 2.265 | 1.811 | 1.994 | 2.790 | 2.620 | 2.612 | 2.597 |
| Cash | 350 | 17 | 624 | 468 | 216 | 876 | 327 | -21 | -21 | -21 |
| Shareholders Funds | 2.736 | 1.372 | 9.222 | 13.515 | 23.150 | 31.912 | 36.077 | 35.640 | 35.532 | 35.333 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 38.432 | 54.799 | 61.481 | 67.405 | 69.622 | 72.707 | 64.894 | 65.116 | 64.919 | 64.556 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Biogrand International Srl